CDKN2B-AS1 and diabetes mellitus: LncRNA ANRIL likewise upregulates VEGF and promotes angiogenesis through the activation of the NF-κB signaling pathway, as was shown in a rat model of diabetes mellitus and cerebral infarction [66].